Clinicopathologic characteristics of esophageal cancer patients in northwest Iran - very low incidence of adenocarcinomas

Asian Pacific Journal of Cancer Prevention

Volumn 7, Issue 3, 2006, Pages 480-482

  Bafandeh, Yousef ^a   Hashemzadeh, Shahriar ^a   Sokouti, Mohsen ^a   Esmaili, Heidar ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Esophageal cancer; Esophagogastric adenocarcinoma; Iran

Indexed keywords

ADENOCARCINOMA; ARTICLE; BARRETT ESOPHAGUS; CARDIA; COMPARATIVE STUDY; CULTURAL ANTHROPOLOGY; ESOPHAGUS TUMOR; FEMALE; HUMAN; INCIDENCE; IRAN; LOWER ESOPHAGUS SPHINCTER; MALE; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK FACTOR; SQUAMOUS CELL CARCINOMA; STOMACH TUMOR;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CARCINOMA, SQUAMOUS CELL; CARDIA; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FEMALE; HUMANS; INCIDENCE; IRAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS; WESTERN WORLD;

EID: 39049184481     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Anikin VA, McManns KG, Graham AN (1997). Total thoracic esophagectomy for esophageal cancer. J Am Coll Surg, 185, 525-9.
2. Bafandeh Y, Esmaili H, Aharizad S (2005). Endoscopic and histologic findings in Iranian patients with heartburn. Ind J Gastroenterol, 24, 236-8.
3. Blaser MJ, Saito D (2002). Trends in reported adenocarcinomas of the esophagus and gastric cardia in Japan. Eur J Gastroentrol Hepatol, 14, 107-13.
4. Blot WJ (1994). Esophageal cancer trends and risk factors. Semin Oncol, 21, 403-10.
5. Bollschweiler E,Wolfgarten E, Gutschow C, Holscher AH (2001). Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer, 92, 549-55.
6. Daly JM, Karnell LH, Menck HR (1996). National Cancer Data Base report on esophageal carcinoma. Cancer, 78, 1820-8.
7. Devesa SS, Blot WJ, Fraumeni JF (1998). Changing patterns in the incidence of esophageal and gastric carcinomas in the United States. Cancer, 83, 2049-53.
8. El-Serag HB, Mason AC, Peterson N, Key CR (2002). Epidemiological differences between adenocarcinoma of the esophagus and adenocarcinoma of the gastric cardia in the USA. Gut, 50, 368-72.
9. Enzinger PC,Mayer RJ (2003). Esophageal cancer. N Engl J Med, 349, 2241-52.
10. Ghavamzadeh A, Moussavi A, Jahani M, Rastgarpanah M, Iravani M (2001). Esophageal cancer in Iran. Semin Oncol, 28, 153-7.
11. Gregory G, Ginsberg, Fleischer DE (2002). Esophogeal tumors. In: Sleisenger and Fordtran's 'Gastrointestinal and liver disease. 7th ed, Philadelphia, Saunders pp 647-71.
12. Islami F, Kamanger F, Aghcheli K, et al (2004). Epidemiologic features of upper gastrointestinal tract cancers in northeastern Iran. Br J Cancer, 90, 1402-6.
13. Kalish RJ,Clancy PE, Orringer M (1984). Clinical, epidemiologic, and morphologic comparison between adenocarcinomas arising in Barrett's esophageal mucosa and in the gastric cardia. Gastroenterology, 86, 461-7.
14. Keighley MRB (2003). Gastrointestinal cancers in Europe. Aliment Pharmacol Ther, 181 suppl, 7-30.
15. Kubo A, Corley DA (2004). Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroentrol, 99, 582-8.
16. Malekzadeh R, Sotoudeh M, Derakhshan MH, et al (2004). Prevalence of gastric precancerous lesions in Ardabi, a high incidence province for gastric adenocarcinoma in the northwest of Iran. J Clin Pathol, 57, 37-42.
17. Marsman WA, Tytgat GNJ, Kate FJW, Lanschot JJB (2005). Differences and similarities of adenocarcinomas of the esophagus and esophagogastric junction. J Surg Oncol, 92, 160-8.
18. Nasseri-Moghaddam S, Malekzadeh R, Sotoudeh M et al (2003). Lower esophagus in dyspeptic Iranian patients. J Gastroentrol Hepatol, 18, 315-21.
19. Pisani P, Parkin DM, Bray F, Ferlay J (1999). Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer, 83, 18-29.
20. Rios-Castellanos E, Sitas F, Shepherd NA, Jewell DP (1992). Changing patterns of gastric cancer in Oxfordshire. Gut, 33, 1312-17
21. Sadjadi A, Nouraie M, Mohagheghi MA, et al (2005). Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev, 6, 359-63.
22. Schouten LJ, Kiemency LA (1997). Remarkable age-dependent sex differences in the incidence of adenocarcinoma of the gastric cardia and esophagus in the Netherlands. Eur J Cancer, 33, 1519.
23. Semnani SH, Besharat S, Abdolahi N, et al (2005). Esophageal cancer in northeastern Iran. Ind J Gastroenterol, 24, 224.
24. Siewert JR, Feith M, Stein HJ (2005). Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification. J Surg Oncol, 90, 139-46.
25. Sotudemanesh R, Nasseri-Moghaddam S, Shirazian N, et al (2001). Prevalence of endoscopic gastroesophageal reflux disease in a 6-year period. Endoscopy, 3, 27.
26. Stein HJ, Feith M, Siewert JR (2000). Cancer of the esophagogastric junction. Surg Oncol, 9, 35-41.
27. Theisen J, Stein HJ, Feith M, et al (2006). Prefered locations for the development of esophageal adenocarcinoma within a segment of intestinal metaplasia. Surg Endoscopy, 20, 235-8.
28. Wang LD, Zheng S, Zheng ZY, Casson AG (2003). Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China. World J Gastroentrol, 9, 1156-64
29. Yuasa N, Hideo M, Tatsuharu Y, et al (2006). Clinicopathologic comparison of Siewert type II and III adenocarcinomas of the gastroesophageal junctiom. World J Surg, 30, 364-71.